{
    "code": 0,
    "data": [
        {
            "sym": "BALAXI",
            "disp": "Balaxi Pharmaceuticals",
            "bse_code": 0,
            "isin": "INE618N01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Investor Presentation",
            "news_body": "BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation",
            "news_id": "nse-9ae87e22daf2225b70a17fe15fcb528e",
            "file_url": "https://nsearchives.nseindia.com/corporate/BALAXI_29012026144532_PRESENTATION_Q3.pdf",
            "news_date": "2026-01-29 00:00:00",
            "seo": "balaxi-pharmaceuticals-ltd",
            "ltp": 22.04,
            "ch": -0.490000000000002,
            "pch": -2.174877940523755,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11309,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BALAXI",
            "disp": "Balaxi Pharmaceuticals",
            "bse_code": 0,
            "isin": "INE618N01022",
            "descriptor": "Outcome of Board Meeting",
            "cat": "Financial Results",
            "caption": "Outcome of Board Meeting",
            "news_body": "BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended December 31, 2025.",
            "news_id": "nse-3b170ec9e94a18525b909f06a8a84c80",
            "file_url": "https://nsearchives.nseindia.com/corporate/BALAXI_28012026144621_28012026.pdf",
            "news_date": "2026-01-28 00:00:00",
            "seo": "balaxi-pharmaceuticals-ltd",
            "ltp": 22.04,
            "ch": -0.490000000000002,
            "pch": -2.174877940523755,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11309,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BALAXI",
            "disp": "Balaxi Pharmaceuticals",
            "bse_code": 0,
            "isin": "INE618N01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Investor Presentation",
            "news_body": "BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation",
            "news_id": "nse-6329a889bf23bd48437059bb7bc04252",
            "file_url": "https://nsearchives.nseindia.com/corporate/BALAXI_14112025151312_INVESTOR_PRESENTATION.pdf",
            "news_date": "2025-11-14 00:00:00",
            "seo": "balaxi-pharmaceuticals-ltd",
            "ltp": 22.04,
            "ch": -0.490000000000002,
            "pch": -2.174877940523755,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11309,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BALAXI",
            "disp": "Balaxi Pharmaceuticals",
            "bse_code": 0,
            "isin": "INE618N01022",
            "descriptor": "Outcome of Board Meeting",
            "cat": "Financial Results",
            "caption": "Outcome of Board Meeting",
            "news_body": "BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2025.",
            "news_id": "nse-987ea8f057fe4a165f157a55567a9c74",
            "file_url": "https://nsearchives.nseindia.com/corporate/BALAXI_11112025143926_OUTCOME_OF_BOARD_MEETING.pdf",
            "news_date": "2025-11-11 00:00:00",
            "seo": "balaxi-pharmaceuticals-ltd",
            "ltp": 22.04,
            "ch": -0.490000000000002,
            "pch": -2.174877940523755,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11309,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}